Partial agonists at 5-HT1A receptor, such as buspirone, are in clinical use as anxiolytics (32, 33), and 5-HT1A antagonists are reported to accelerate the therapeutic effects of antidepressant medications and increase anxiety (-). Here, HTR1A is linked to Anxiety.